Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Extended release oral dosage composition

Extended release oral dosage composition

US Patent 6709676 · Granted Mar 23, 2004

Estimated economic value: $71,103,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.02013
Tablet formulations containing 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-m2013
Extended release oral dosage composition2012
Pharmaceutical formulations and methods of treatment using the same2010
Pharmaceutical formulation2010
Extended release oral dosage composition2009
Methods for inhibiting sterol absorption2009
Sterol absorption inhibitor compositions2006
Sustained release tablet comprising loratadine, ibuprofen and pseudoephedrine1992
Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine1991